Three-dimensional conformal radiotherapy for the treatment of arteriovenous shunting in patients with hepatocellular carcinoma

H C Hsu; T Y Chen; K W Chiu; E Y Huang; S W Leung; Y J Huang; C Y Wang
January 2007
British Journal of Radiology;Jan2007, Vol. 80 Issue 949, p38
Academic Journal
The objective of this study is to evaluate the efficacy of radiotherapy for the treatment of arteriovenous shunting (AVS) in patients with hepatocellular carcinoma (HCC). Between November 1997 and April 2005, 20 HCC patients with AVS were referred to our department for radiotherapy. The radiation was delivered with 10-15 MV X-ray given 5 days per week at 2 approximately 2.5 Gy per fraction. Total doses ranged from 45 to 64 Gy (median dose 60 Gy). The patients were followed up with color Doppler sonography. When non-invasive imaging suggested obliteration, X-ray angiography was performed to verify the results. Four of the 20 AVS proved to be completely obliterated at X-ray angiography in 1.9, 2.8, 1.8 and 2.9 months after radiotherapy. One of the remaining 16 showed obvious regression on Doppler sonography 0.5 months after radiotherapy, but X-ray angiography was not performed to verify the result. Radiation-related hepatic failure did not occur during the follow-up period. In conclusion, radiotherapy is a treatment alternative for AVS in HCC patients and gives patients with poor prognosis the chance to receive further transcatheter arterial embolization.


Related Articles

  • Changes of the liver volume and the Child-Pugh score after high dose hypofractionated radiotherapy in patients with small hepatocellular carcinoma. Young Il Kim; Hee Chul Park; Do Hoon Lim; Hyo Jung Park; Sang Won Kang; Su Yeon Park; Jin Sung Kim; Youngyih Han; Seung Woon Paik // Radiation Oncology Journal;Dec2012, Vol. 30 Issue 4, p189 

    Purpose: To investigate the safety of high dose hypofractionated radiotherapy (RT) in patients with small hepatocellular carcinoma (HCC) in terms of liver volumetric changes and clinical liver function. Materials and Methods: We retrospectively reviewed 16 patients with small HCC who were...

  • University of Maryland Greenebaum Cancer Center Adds SIR-Spheres to Arsenal of Targeted Therapies for Liver Cancer.  // Ascribe Newswire: Medicine;6/10/2004, p139 

    The University of Maryland Greenebaum Cancer Center is now treating patients who have inoperable liver cancer with a state-of-the-art internal radiation therapy called SIR-Spheres that uses millions of microscopic radioactive beads to help destroy tumors from the inside out. SIR-Spheres deliver...

  • Primary Hepatic Lymphoma: A Diagnosis to Remember. Warner, Ben; Bird, George; Schofield, John; Rassam, Saad // Journal of Medical Cases;2013, Vol. 4 Issue 1, p52 

    We present 2 cases of PHL presenting to our hospital in the last 6 months. Both cases had similarities in that they had a rapidly progressive time course of less than 8 weeks and radiology failed to illustrate the normal disease pattern. Both were elderly men presenting with jaundice, rare...

  • Continuing Medical Education Questions: April 2014. DeVault, Kenneth R; Badillo, Raul J; Bartel, Michal J // American Journal of Gastroenterology;Apr2014, Vol. 109 Issue 4, p484 

    The article presents questions and answers related to gastrointestinal angiodysplastic lesions (GAL) including effective medications used to prevent rebleeding from GAL, endoscopic therapy for treatment of GIADs, and the role of Heyde's syndrome on GIAD.

  • Therapy on target. Becker, Cinda // Modern Healthcare;06/11/2001, Vol. 31 Issue 24, p34 

    Talks about intensity modulated radiation therapy (IMRT) which allows radiologists to target and attack tumors fullgun while sparing healthy tissue. Companies that offer IMRT products; Theories regarding precision-targeting; Information on the payment codes for IMRT.

  • NSD in ret.  // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p1600 

    An encyclopedia entry for "NSD in ret" is presented, referring to the abbreviation for nominal standard dose in radiation equivalent therapy.

  • LIVER BEADS.  // Science Teacher;Sep2000, Vol. 67 Issue 6, p22 

    Reports that a method for treating liver cancer with radioactive glass beads has been approved for use in the United States. Mechanism of action; Treatment safety.

  • Pilot Study of Local Radiotherapy for Portal Vein Tumor Thrombus in Patients with Unresectable Hepatocellular Carcinoma. Yamada, Kazunari; Soejima, Toshinori; Sugimoto, Koji; Mayahara, Hiroshi; Izaki, Kenta; Sasaki, Ryohei; Maruta, Tsutomu; Matsumoto, Shinichi; Hirota, Shozo; Sugimura, Kazuro // Japanese Journal of Clinical Oncology;Apr2001, Vol. 31 Issue 4, p147 

    Background: Patients suffering from hepatocellular carcinoma (HCC) with portal vein tumor thrombus (PVTT) generally have a poor prognosis. We therefore conducted a prospective pilot trial of combined transcatheter arterial chemoembolization (TACE) and local radiotherapy (RT) for PVTT in...

  • Preoperative angiographic selective methylene blue staining of large bowel angiodysplasia in an elderly patient case report. Stanojević, Goran; Mihailović, Dragan; Bošnjaković, Petar; Branković, Branko; Nestorović, Milica; Vesna, Brzački // International Journal of Colorectal Disease;Feb2012, Vol. 27 Issue 2, p261 

    A letter to the editor is presented which discusses the condition of an 80-year-old man who was diagnosed with colonic angiodysplasia and went through a preoperative angiographic with selective methylene blue application before the surgery.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics